ethris GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:ethris GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014226
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ethris GmbH (Ethris) is a biotechnology company that develops and manufactures therapeutics. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris’ magnetovax is a platform for personalized tumor vaccines localized and activated in tumors by magnetic fields and transports nucleic acid agents. The company’s drug candidates include ETH-CFTR, ETH-CCDC40, ETH-CCNO and ETH-OTC. It partners with academic and medical institutions in Germany and abroad for its research and development activities. Ethris is headquartered in Planegg, Germany.

ethris GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ethris GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
ethris GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ethris GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ethris Enters into Research Agreement with Astrazeneca and MedImmune 10
Ethris Enters Into Agreement With Shire Human Genetic Therapies For RNA-Based Therapeutics 11
Licensing Agreements 12
Ethris Enters Into Licensing Agreement With Bayerische Patentallianz 12
ethris GmbH – Key Competitors 13
ethris GmbH – Key Employees 14
ethris GmbH – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Jul 19, 2016: Ethris Adds Three New Members to its Board of Directors 16
Product News 17
Mar 21, 2016: Ethris Publishes Preclinical Data on Musculoskeletal Regeneration Using its Novel mRNA-based Transcript Therapy Approach 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
ethris GmbH, Pharmaceuticals & Healthcare, Key Facts 2
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ethris GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ethris GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
ethris GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ethris Enters into Research Agreement with Astrazeneca and MedImmune 10
Ethris Enters Into Agreement With Shire Human Genetic Therapies For RNA-Based Therapeutics 11
Ethris Enters Into Licensing Agreement With Bayerische Patentallianz 12
ethris GmbH, Key Competitors 13
ethris GmbH, Key Employees 14

★海外企業調査レポート[ethris GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Texas A&M University-製薬・医療分野:企業M&A・提携分析
    Summary Texas A&M University (TAMU) is a research based university that offers educational and research services. The university provides undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences …
  • Rexahn Pharmaceuticals Inc (RNN):企業の財務・戦略的SWOT分析
    Summary Rexahn Pharmaceuticals Inc (Rexahn Pharmaceuticals), formerly Corporate Road Show.com Inc is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer. The company develops anti-cancer drug candidates including Archexin that is intended for the tre …
  • Constant Contact, Inc.:企業の戦略・SWOT・財務分析
    Constant Contact, Inc. - Strategy, SWOT and Corporate Finance Report Summary Constant Contact, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nightstar Therapeutics PLC (NITE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nightstar Therapeutics PLC (Nightstar Therapeutics), formerly Nightstar Therapeutics Ltd, is a clinical-stage gene therapy company. The company focus on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. Its lead product cand …
  • Independent News & Media Plc:企業の戦略的SWOT分析
    Independent News & Media Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Edisun Power Europe AG (ESUN):企業の財務・戦略的SWOT分析
    Summary Edisun Power Europe AG (Edisun Power) is a solar power producer. The company finances, develops and operates solar power plants in various European countries. It offers technical studies, legal and financial studies, custom design, installation, work monitoring, and operation and maintenance …
  • ARMZ Uranium Holding Co:企業の戦略的SWOT分析
    ARMZ Uranium Holding Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Elmet Technologies Inc:企業の戦略・SWOT・財務分析
    Elmet Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Elmet Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Midland Power Cooperative:発電所・企業SWOT分析
    Midland Power Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Sun Resources NL (SUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Sun Resources NL (Sun Resources) is an oil and gas exploration and development company. The company explores and develops crude oil and natural gas. Its services include exploration, production, and development of unconventional oil and gas resources. Its projects include Delta Oil Project, …
  • Motorola Solutions, Inc.:企業の戦略・SWOT・財務情報
    Motorola Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Motorola Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CTD Holdings Inc (CTDH):製薬・医療:M&Aディール及び事業提携情報
    Summary CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropy …
  • Corning Inc (GLW):電力:M&Aディール及び事業提携情報
    Summary Corning Inc (Corning) manufactures and sells ceramics, specialty glasses, and related materials. The company offers glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for telecommunications networks; ceram …
  • Western Energy Services Corp (WRG):石油・ガス:M&Aディール及び事業提携情報
    Summary Western Energy Services Corp (Western) is an oilfield service company that offers contract drilling, well services and oilfield rental equipment services. The company offers services through Horizon Drilling, Eagle Well Servicing and Stoneham Drilling Corporation. It also provides rental ser …
  • Barco N.V.:企業の戦略・SWOT・財務情報
    Barco N.V. - Strategy, SWOT and Corporate Finance Report Summary Barco N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lisi Aerospace SAS:戦略・SWOT・企業財務分析
    Lisi Aerospace SAS - Strategy, SWOT and Corporate Finance Report Summary Lisi Aerospace SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Culture Landmark Investment Ltd
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive in …
  • Spero Therapeutics Inc (SPRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Spero Therapeutics Inc. (Spero) is a clinical-stage biopharmaceutical company. It is engaged in developing, identifying and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections. Its product pipeline includes SPR994 oral gram-negative program, SPR741and SPR206 …
  • Qualcomm Incorporated (QCOM)-医療機器分野:企業M&A・提携分析
    Summary Qualcomm Incorporated (Qualcomm) is a technology and communication company. The company designs and manufactures digital wireless telecommunications products and services. Qualcomm offers integrated circuits and system software for wireless mobile devices. The major technologies such as code …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆